These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19051144)

  • 1. Inflammation Research Association--15th international conference advances in asthma and COPD and other inflammatory diseases.
    Walker K
    IDrugs; 2008 Dec; 11(12):863-5. PubMed ID: 19051144
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids: the drugs to beat.
    Barnes PJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of transcription factors in the pathogenesis of asthma and COPD.
    Caramori G; Casolari P; Adcock I
    Cell Commun Adhes; 2013 Feb; 20(1-2):21-40. PubMed ID: 23472830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in mechanisms influencing glucocorticoid sensitivity: the need for a systems biology approach to treatment of glucocorticoid-resistant inflammation.
    Keenan CR; Radojicic D; Li M; Radwan A; Stewart AG
    Pharmacol Ther; 2015 Jun; 150():81-93. PubMed ID: 25596317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapies for the treatment of inflammatory airway disease.
    Hele DJ; Belvisi MG
    Expert Opin Investig Drugs; 2003 Jan; 12(1):5-18. PubMed ID: 12517250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription inhibitors and inflammatory cell activity.
    Caramori G; Coppolino I; Cannavò MF; Nucera F; Proietto A; Mumby S; Ruggeri P; Adcock IM
    Curr Opin Pharmacol; 2019 Jun; 46():82-89. PubMed ID: 31207387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.
    Barnes PJ
    Pharmacol Rev; 2016 Jul; 68(3):788-815. PubMed ID: 27363440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach.
    Mroz RM; Noparlik J; Chyczewska E; Braszko JJ; Holownia A
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):453-60. PubMed ID: 18204158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory properties of the monoterpene 1.8-cineole: current evidence for co-medication in inflammatory airway diseases.
    Juergens UR
    Drug Res (Stuttg); 2014 Dec; 64(12):638-46. PubMed ID: 24831245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting 5-lipoxygenase-activating protein in asthma and chronic obstructive pulmonary disease.
    Antoniu SA
    Expert Opin Ther Targets; 2014 Nov; 18(11):1285-92. PubMed ID: 25213852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment in asthma and COPD.
    Hoshino T; Toda R; Aizawa H
    Allergol Int; 2009 Sep; 58(3):341-6. PubMed ID: 19628978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease.
    Durham AL; Caramori G; Chung KF; Adcock IM
    Transl Res; 2016 Jan; 167(1):192-203. PubMed ID: 26334389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R(15, 20, 21), L(17), A(24,25), des-N(28)]-VIP-GRR) in experimental asthma/COPD model rats.
    Onoue S; Aoki Y; Matsui T; Kojo Y; Misaka S; Mizumoto T; Yamada S
    Int J Pharm; 2011 May; 410(1-2):54-60. PubMed ID: 21419198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and existing pharmacotherapeutic options for persistent asthma and COPD.
    Diamant Z; Tarasevych S; Clarke GW
    Neth J Med; 2011; 69(11):486-99. PubMed ID: 22173362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Asthma and COPD Forum. Tackling asthma, COPD and allergic diseases.
    D'Amato G
    IDrugs; 2008 Jul; 11(7):486-8. PubMed ID: 18600593
    [No Abstract]   [Full Text] [Related]  

  • 17. Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?
    Beeh KM; Beier J
    Clin Exp Allergy; 2006 Feb; 36(2):142-57. PubMed ID: 16433851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase inhibitors and airway inflammation.
    Adcock IM; Chung KF; Caramori G; Ito K
    Eur J Pharmacol; 2006 Mar; 533(1-3):118-32. PubMed ID: 16469308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease.
    Woodside DG; Vanderslice P
    BioDrugs; 2008; 22(2):85-100. PubMed ID: 18345706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the CAT-262C>T polymorphism with asthma in smokers and the nonemphysematous phenotype of chronic obstructive pulmonary disease.
    Taniguchi N; Konno S; Isada A; Hattori T; Kimura H; Shimizu K; Maeda Y; Makita H; Hizawa N; Nishimura M
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):31-36.e2. PubMed ID: 24824229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.